Case Report
Copyright ©The Author(s) 2020.
World J Clin Cases. Oct 26, 2020; 8(20): 4858-4865
Published online Oct 26, 2020. doi: 10.12998/wjcc.v8.i20.4858
Table 1 Characteristics of previously reported carotid blowout syndrome after completion of concurrent chemoradiotherapy
Ref.
Year
No. of total patients
Rupture type, acute/ impending/ threatened
Radiation dose
Time to develop CBS from diagnosis (mo)
Survival time
Treatment category
Re-bleeding after treatment (n)
Neurological sequelae (n)
Roh et al[10]200816Acute: 8; Impending: 7; Threatened: 778.5 Gy (46–127)23 mo (3-142)5 mo (1-21)Endovascular intervention: 165 (31%)3 (19%)
Luo et al[12]200814(-)73 Gy (54-110)33 mo (8-70)21 mo (4-48)Endovascular intervention: 14(-)3 (21%)
Chen et al[13]201587Acute: 34; Impending: 5373 Gy (SD, 29.6)31 mo (SD, 27.2)Died within 30 d: 19 (52.9%)Endovascular intervention: 71, Surgery: 1640 (46%)13 (15%)
Chang et al[14]201596Acute: 47; Ongoing: 49(-)3.5 yr (0.2–34, SD 2.8)10 mo (0.07–110, SD 34.1)Endovascular intervention: 9626 (27%)19 (20%)
Liang et al[15]201637Acute: 25; Impending: 9; Threatened: 3(-)478 d (246-1752)90-d/1-yr estimated survivals: 60.9%/36.6%Endovascular intervention: 25; Surgery: 1211 (30%)4 (11%)